Blue Horseshoe Stocks: PIRS Review & More

Pieris Pharmaceuticals Inc. PIRS – Review

Of all the types of plays we search for, bottom watch plays can require the most amount of patience as compared to other quick-strike ideas that we formulate. We highlighted PIRS as such back in mid-February, and over the past quarter, the stock has produced some very favorable results in two distinct runs.

When we initially signaled our interest in this stock, or shortly thereafter, it was trading for as little as 2.83 and over the course of the next two months, it gradually made its way to 4.00 (+41%). After a pullback down near its original level at 2.81 halfway through last month, the stock has begun to run once again. This time it has reached all new highs, with the stock changing hands for as much as 4.68/share on Friday. That second push allowed us to see an overall increase of 67%

We wouldn’t be at all surprised to have to come back to PIRS once again in the near future. In addition to the company’s joint clinical venture with pharma super giant AstraZeneca, the stock itself has recently received analyst upgrades that could just be the beginning of PIRS’s next leg-up.


Xalles Holdings, Inc. XALL

We are also looking at the incredible momentum recently built up by XALL, which has been assisted by the resurgence of Bitcoin here in 2019, which began in January in the mid-$3000 range, and has persisted to the present time to the current highs near $8700.

The company also recently decreased its public float by around 50%, making it that much easier for the stock to move. We’ll be interested to continue to monitor its progress, especially if the latest Bitcoin boom continues to persist as it has in recent months.


Extended Watchlist:
DRRX, CBLK, BLNK, CTRV, MOSY, SNSS, NVCN, ATVI, LAHO(>>News Alert)

Blue Horseshoe Stocks: Fresh Options Ideas & More

OPTIONS UPDATES

Activision Blizzard. Inc. ATVI – To follow up with our idea from Wednesday morning in our premarket report, the ATVI Weekly $42-43.50 Calls, we wanted to provide one more update after another big move from the stock pushed our highlighted targets to new highs yesterday, and registered a really impressive two-day swing.

The following moves are the overall increases from the lows we observed on Wednesday: 

$42 Calls – 1.32-4.50 (+241%)
$42.50 Calls – .98-4.00 (+308%)
$43 Calls – .70-3.50 (+400%)
$43.50 Calls –  .44-3.05 (+593%)

Today, we are going to turn our attention to a slightly higher strike area, the ATVI Weekly $44.50-46 Calls*.
____

AstraZeneca plc AZN – The AZN Weekly $38-39.50 Calls  were on our radar yesterday morning as our fresh options idea, and despite the lower end of that range being pushed too far in the money, we still saw some solid moves out of the $39’s and $39.50’s.

The $39’s ran from .55-.90 for a gain of 64%, while the $39.50’s cruised from a low of .19 to hit .55; a big-time intraday pop of 189%  We want to continue to watching this chain as well, with the 39.50’s, and also rolling up to include the $40 and $40.50’s*.
____

FRESH IDEAS:

SPY Weekly $274.50-276 Calls*
CGC Weekly $46.50-48 Calls*
EA Weekly $107-109 Calls*
____

*Trading Weekly contracts on Friday should not be attempted unless you are an expert level trader with disposable funds.


Invacare Corp. IVC – Recap

Also appearing in yesterday’s report, was IVC, which we tagged in our extended watchlist. The stock made a good move on the day, which warrants further observation in coming sessions.

From a low of 7.21 IVC reached 9.54, which was good for an intraday rise of 32% which made it the second highest gainer on the NASDAQ for Thursday. We’ll continue to monitor this one as well.


Extended Watchlist:
ARSN, CBAY, SLDB, ICON, NGL, ADMA

Blue Horseshoe Stocks: ATVI Winners & More

Activision Blizzard. Inc. ATVI – Big Winner

We signaled a range of calls in the Activision chain yesterday morning in our premarket report following the company’s earnings report, which were bullish despite the fact that ATVI’s quarterly figures were a disappointment. We indicated that we would put the ATVI Weekly $42-43.50 Calls on watch, and they were good ideas across the board.

In each of our designated contract sets, we saw not one, but two remarkable intraday swings, that gave traders plenty of chances for single-session profits of a significant nature. We’ve listed all the moves and total possible gains below:

$42 Calls – Move #1: 1.48-3.20 (+116%)  | Move #2: 1.32-3.35 (+154%)
$42.50 Calls – Move #1: 1.12-2.75 (+146%) | Move #2: .98-2.85 (+191%)
$43 Calls – Move #1: .89-2.32 (+161%) | Move #2: .70-2.40 (+243%)
$43.50 Calls – Move #1: .70-1.90 (+171%) | Move #2: .44-1.90 (+332%)
____

Fresh Options Idea:

AstraZeneca plc AZN Weekly $38-39.50 Calls


Pernix Therapeutics Holdings, Inc. PTX

Even as we continue our excellent 2019 track record for options ideas, we don’t want to forget about the stocks on our watchlist that have been performing well.

A fantastic example of that is a stock we tagged as a bottom watch play back on December 20th. Over the past seven weeks, the stock has ramped up quite impressively, leading to a new high yesterday that we wanted to recap today.

From our observed low of .32 on PTX subsequent to our alert, to yesterday’s new high, represents an increase of 588%


Extended Watchlist:
OHGI, AY, SNBR, IVC, CHEK, AKAO, TELL, BRS, PS, SOLO